← Human Trials & Peer-Reviewed Studies
Growth hormone-releasing effects of whole body vibration alone or combined with squatting plus external load in severely obese female subjects.
Plain-language guide to PMID 22922806 (2012): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 7 women.
Key Facts
- PMID
- 22922806
- Journal
- Obesity facts
- Year
- 2012
- Study type
- Randomized Controlled Trial
- Authors
- Giunta M et al. (7 authors)
- DOI
- 10.1159/000342066
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Whole body vibration (WBV) has been reported to exert growth hormone(GH)-releasing effects in healthy subjects.
Despite the potential of WBV to positively affect body composition changes via lipolytic effects, few studies have been performed in obese subjects to date.
Who Took Part
The abstract describes 7 women taking part.
PubMed indexes the participants as teenagers, young adults and adults, women only.
This study evaluated the acute effects of WBV alone or in combination with squatting plus external load (WBV+S) on serum GH levels and blood lactate concentrations in 7 severely obese women (age 22 ± 5 years; BMI 39.9 ± 2.9 kg/m2).
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
Topics PubMed links to this paper include Exercise, Human Growth Hormone, Lactic Acid, Obesity, Morbid, Resistance Training, Vibration and Weight-Bearing.
What This Means in Plain Language
The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 7 women.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2012 (Obesity facts), a journal based in Switzerland.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.